Résultats de la recherche

search

Rechercher les filtres

Mot-clé
ptsd
Sparkling Ice and K9s For Warriors are saving lives at both ends of the leash.
Talking Rain and K9s For Warriors unleash co-branded Sparkling Ice six-packs
24 mars 2025 12h00 HE | Talking Rain Beverage Company
PRESTON, Wash., March 24, 2025 (GLOBE NEWSWIRE) -- Today Sparkling Ice®, crafted by Talking Rain Beverage Company®, reconfirmed its commitment to “saving lives at both ends of the leash” with the...
PTSD; Phase II Clinical Trial; Lithium Salicylate with Proline; LiProSal; LisPro; AL001; Massachusetts General Hospital;
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital
11 mars 2025 08h00 HE | Alzamend Neuro, Inc.
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial for AL001 Treatment of Post-Traumatic Stress Disorder at Massachusetts General Hospital
Bipolar Disorder Statement
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital
04 mars 2025 08h10 HE | Alzamend Neuro, Inc.
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder at Massachusetts General Hospital
PharmAla Biotech Logo 800 x 422.png
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA
27 févr. 2025 14h45 HE | PharmAla Biotech
PharmAla to supply the STRONG STAR Consortium with new 20mg MDMA dose to treat active-duty military personnel in a clinical trial
PharmAla Biotech Logo 800 x 422.png
PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel
20 janv. 2025 08h55 HE | PharmAla Biotech
PharmAla partners with Merhavim and MAPS Israel for innovative MDMA PTSD clinical trial data sharing partnership in wake of Gaza Ceasefire
Halberd Update on WatchDawg® PTSD Treatment
Halberd Update on WatchDawg® PTSD Treatment
02 déc. 2024 08h00 HE | Halberd Corp.
Halberd Update on WatchDawg® PTSD Treatment
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Successfully Clears Path for Cannabis Research through FDA Formal Dispute After three years of negotiation with the FDA, MAPS has successfully secured FDA clearance to conduct a clinical trial, MJP2, to examine the use of smoked cannabis for the treatment of PTSD symptoms...
EC-Logo-2018_TM_CMYK.jpg
electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis
19 nov. 2024 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has donated 20 gammaCore...
PharmAla Biotech Logo 800 x 422.png
PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License
14 nov. 2024 09h20 HE | PharmAla Biotech
PharmAla reaches agreement in principle to trade with a clinical trial to trade its LaNeo MDMA for a data license to the trial outcomes.
Aviv-Clinic Logo.png
Aviv Clinics Unveils Compelling Results on Treatment for Veterans Suffering from Post-Traumatic Stress Disorder
13 nov. 2024 08h52 HE | Aviv Clinics
ORLANDO, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced brain health clinics in the world, shares the results of a groundbreaking study revealing a specialized...